Sales and Marketing

Showing 15 posts of 11527 posts found.

Pharma prepares for battle over EU patient information

October 14, 2008 Sales and Marketing EU, patients, reform

 A collective of European legislators, patient groups and the pharma industry have reiterated the call for Europe’s ban on pharma …

Johnson & Johnson appoints new global pharma chair

October 14, 2008 Sales and Marketing JJ

Johnson & Johnson has named a new chairman for its struggling pharmaceuticals group, and kept the role under female leadership. …

Working Life: Dr Zubair Hussain

October 13, 2008 Business Services, Research and Development, Sales and Marketing Pfizer, UK, careers, recruitment, reg affairs

How did you get into your current role After completing my D.Phil at Oxford, I looked for an opportunity in …

Latest news from Datamonitor

October 13, 2008 Sales and Marketing HIV

Battle for HIV drug market share getting fiercerThe HIV market, worth $9.3 billion in 2007, is expected to grow to …

Novartis pursues pulmonary hypertension indication for Glivec

October 10, 2008 Sales and Marketing

Novartis says new data on Glivec shows it has potential to treat a life-threatening heart condition, despite failing to meet …

Lilly eyes oncology focus with ImClone acquisition

October 9, 2008 Sales and Marketing Cancer, MA, lilly

Lilly is to buy ImClone for $6.5 billion after outbidding Bristol-Myers Squibb for the biotech company. Lilly says the acquisition …

GlycArt’s new cancer candidate to be developed with Roche

October 9, 2008 Research and Development, Sales and Marketing GlycArt, Roche

Roche is to develop a potential cancer therapy with two business partners. Genentech, the Swiss biotech company GlycArt – wholly-owned …

Latest news from Datamonitor

October 6, 2008 Sales and Marketing OTC

Is an Rx-to-OTC move the right prescription to protect pharma revenues and cut healthcare costs? The growing cost of developing …

Emerging confidence

October 2, 2008 Research and Development, Sales and Marketing emerging markets, evidence-based medicine

 The wisdom that emerging markets are vital to the pharmaceutical and biotechnology industry’s future has become a lot more conventional …

Osteoporosis drug Aclasta approved for use in men

October 2, 2008 Sales and Marketing Novartis, aclasta, osteoporosis

Osteoporosis treatment Aclasta has been approved for an extended indication in the European Union.Novartis’ once-yearly infusion has now been given …

Long-acting Zyprexa gets green light

October 2, 2008 Sales and Marketing lilly, psych

Lilly's Zypadhera has been recommended in Europe for use in stabilising schizophrenic patients who are already receiving treatment. The European …

Spiriva partners defend drug’s safety

October 2, 2008 Sales and Marketing Boehringer, COPD, Spiriva, resp

Boehringer Ingelheim and Pfizer have released new data on Spiriva to defend the safety record of the chronic obstructive pulmonary …

Weak currency helps UK pharmaceutical industry

October 1, 2008 Manufacturing and Production, Sales and Marketing parallel trade

Pharmaceutical companies operating in the UK are experiencing reduced competition from European parallel importers, thanks to the weakness of the …
The Gateway to Local Adoption Series

Latest content